Actrapid and Ventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Ventricular tachycardia is reported as a side effect among people who take Actrapid (insulin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Abdominal pain.

The phase IV clinical study analyzes which people have Ventricular tachycardia when taking Actrapid. It is created by eHealthMe based on reports of 4,843 people who have side effects when taking Actrapid from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,290 drugs and 2,096 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.

On Jul, 18, 2026

4,843 people reported to have side effects when taking Actrapid.
Among them, 25 people (0.52%) have Ventricular tachycardia.

Could Actrapid cause Ventricular tachycardia?

Among these 25 people:

How long have people been on Actrapid when they have Ventricular tachycardia? *

What is the gender of people who have Ventricular tachycardia when taking Actrapid? *

female: 24 %
male: 76 %

What is the age of people who have Ventricular tachycardia when taking Actrapid? *

What are other drugs people take besides Actrapid? *

What are other side effects people have besides Ventricular tachycardia? *

Dyspnea (difficult or laboured breathing): 14 people, 56.00%
Fatigue (feeling of tiredness): 14 people, 56.00%
Thrombocytopenia (decrease of platelets in blood): 12 people, 48.00%
Ventricular Extrasystoles (premature cardiac contraction): 9 people, 36.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 32.00%
Fever: 8 people, 32.00%
Weakness: 8 people, 32.00%
Chest Pain: 8 people, 32.00%
Hypokalemia (low potassium): 8 people, 32.00%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 8 people, 32.00%

What are the existing conditions these people have? *

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 7 people, 28.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 7 people, 28.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 28.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 28.00%
Depression: 7 people, 28.00%
Diabetes: 7 people, 28.00%
Essential Hypertension (primary hypertension): 7 people, 28.00%
Itching: 7 people, 28.00%
Abdominal Pain: 7 people, 28.00%
Cardiac Failure: 6 people, 24.00%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and have Ventricular tachycardia?

- Check whether Ventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actrapid:

Actrapid (4,864 reports)

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular tachycardia:

Ventricular tachycardia (1,290 drugs)

Browse all the conditions that are associated with Ventricular tachycardia:

Ventricular tachycardia (2,096 conditions)

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on insulin (the active ingredients of Actrapid) and Actrapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.